IONQ encountered a setback this week as Da Davidson analyst Alexander Platt downgraded the company’s shares but kept a price target of $35. Analysts pointed to increasing uncertainty about IONQ’s strategic direction and its profitability outlook. This downgrade comes after IONQ released a mixed report on Q2 revenues.
Main reasons for downgrade
Platt highlighted that while IONQ has made significant investments in quantum computing, a potentially groundbreaking technology, there are concerns regarding the company’s unclear plans and the uncertain path to short-term profitability. He also noted that the associated risks of the business appear to be “particularly increasing.”
Morgan Stanley Analyst UPS Target
On the other hand, Joseph Moore from Morgan Stanley raised IONQ’s price target from $30 to $32, maintaining a hold rating. He sees promising long-term opportunities in quantum technology, especially in AI and simulation. Moore believes the quantum market might hit $65 billion by 2030, with AI potentially surpassing $200 billion. He mentioned that IONQ could be in competition with larger firms and might find itself in a challenging position.
IONQ’s quantum jump
IONQ is making strides in the quantum computing realm. Its hybrid quantum-classical computing can enhance the accuracy of tasks like sentiment analysis and reduce energy consumption with additional qubits. This approach shows promise in fields such as materials science, biology, and language processing.
Furthermore, IONQ is advancing into quantum networking, envisioning a space-based system for secure key sharing. Its products are currently utilized by major banks, communication firms, and government agencies to guard against potential quantum hacking.
Notably, IONQ has partnered with major players like Amazon AWS, Microsoft Azure, and Google Cloud, and has launched a quantum application center with Astrazeneca. They are also exploring engineering simulations for manufacturing.
Is IONQ a good purchase?
Looking at analyst sentiment, IONQ has a strong buy consensus based on five buy ratings and two holds in the last three months. With an average target price of $49.17, this suggests a potential upside of about 21.44% for the stock.
